Ambisome

In the US, Ambisome (amphotericin b liposomal systemic) is a member of the drug class polyenes and is used to treat Aspergillosis - Invasive, Candida Infections - Systemic, Cryptococcal Meningitis - Immunosuppressed Host, Cryptococcosis, Febrile Neutropenia and Leishmaniasis.

US matches:

• Ambisome

UK matches:

• AmBisome (SPC)

Ingredient matches for Ambisome

Amphotericin B

Amphotericin B is reported as an ingredient of Ambisome in the following countries:

• Greece

Amphotericin B liposoma (a derivative of Amphotericin B) is reported as an ingredient of Ambisome in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Canada


• Denmark


• Finland


• France


• Germany


• Iceland


• Ireland


• Israel


• Italy


• Japan


• Latvia


• Luxembourg


• Netherlands


• New Zealand


• Norway


• Poland


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Turkey


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.